Hologic
HOLX
NZ$106.97
Share price
-0.63%
Change (1 day)
-12.00%
Change (1 year)
Categories
Hologic, Inc. is an American medical technology company primarily focused on women’s health, the company sells medical devices for diagnostics, surgery, and medical imaging.
Market capitalization of Hologic (HOLX)
Market cap: NZ$23.83 Billion
As of July 2025 Hologic has a market cap of NZ$23.83 Billion. This makes Hologic the world's 1390th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Hologic from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$23.83 B | -18.4% |
| 2024 | NZ$29.21 B | 7.74% |
| 2023 | NZ$27.11 B | -6.39% |
| 2022 | NZ$28.96 B | 2.59% |
| 2021 | NZ$28.23 B | 8.84% |
| 2020 | NZ$25.94 B | 26.81% |
| 2019 | NZ$20.45 B | 14.79% |
| 2018 | NZ$17.82 B | 7.39% |
| 2017 | NZ$16.59 B | 2.98% |
| 2016 | NZ$16.11 B | 0.53% |
| 2015 | NZ$16.02 B | 68.05% |
| 2014 | NZ$9.53 B | 28.26% |
| 2013 | NZ$7.43 B | 14.43% |
| 2012 | NZ$6.49 B | 10.05% |
| 2011 | NZ$5.90 B | -6.91% |
| 2010 | NZ$6.34 B | 23.02% |
| 2009 | NZ$5.15 B | -10.64% |
| 2008 | NZ$5.77 B | -49.39% |
| 2007 | NZ$11.40 B | 222.43% |
| 2006 | NZ$3.53 B | 42.36% |
| 2005 | NZ$2.48 B | 206.47% |
| 2004 | NZ$0.81 B | 52.24% |
| 2003 | NZ$0.53 B | 16.94% |
| 2002 | NZ$0.45 B | 8.15% |
| 2001 | NZ$0.42 B | 127.81% |
| 2000 | NZ$0.18 B | 9.99% |
| 1999 | NZ$0.16 B | -45.49% |
| 1998 | NZ$0.30 B | -34.26% |
| 1997 | NZ$0.46 B | 3.86% |
| 1996 | NZ$0.45 B |
End of Day market cap according to different sources
On Jul 7th, 2025 the market cap of Hologic was reported to be:
NZ$23.83 Billion
NZ$23.83 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | NZ$269.32 B | 1,029.84% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$83.90 B | 251.97% | 🇺🇸 USA |
 Boston Scientific BSX | NZ$255.27 B | 970.87% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$388.70 B | 1,530.62% | 🇺🇸 USA |
 General Electric GE | NZ$440.63 B | 1,748.49% | 🇺🇸 USA |
 Philips PHG | NZ$36.71 B | 54.02% | 🇳🇱 Netherlands |
 Quest Diagnostics
DGX | NZ$32.27 B | 35.39% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$623.79 B | 2,516.83% | 🇺🇸 USA |